ALX Oncology

ALX Oncology logo
🇺🇸United States
Ownership
Public, Subsidiary
Established
2015-01-01
Employees
72
Market Cap
$131.1M
Website
http://www.alxoncology.com
Introduction

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications. The company was founded by Corey Goodman, Jaume Pons, a...

© Copyright 2024. All Rights Reserved by MedPath